BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 29330296)

  • 21. Thymosin beta4 triggers an epithelial-mesenchymal transition in colorectal carcinoma by upregulating integrin-linked kinase.
    Huang HC; Hu CH; Tang MC; Wang WS; Chen PM; Su Y
    Oncogene; 2007 Apr; 26(19):2781-90. PubMed ID: 17072345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thymosin beta4 in multiple myeloma: friend or foe.
    Caers J; Otjacques E; Hose D; Klein B; Vanderkerken K
    Ann N Y Acad Sci; 2010 Apr; 1194():125-9. PubMed ID: 20536459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymosin β4 expression reveals intriguing similarities between fetal and cancer cells.
    Faa G; Nemolato S; Cabras T; Fanni D; Gerosa C; Fanari M; Locci A; Fanos V; Messana I; Castagnola M
    Ann N Y Acad Sci; 2012 Oct; 1269():53-60. PubMed ID: 23045970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thymosin β4 attenuates liver fibrosis via suppressing Notch signaling.
    Hong Y; Yao Q; Zheng L
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1396-1401. PubMed ID: 28965947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thymosin β4-Enhancing Therapeutic Efficacy of Human Adipose-Derived Stem Cells in Mouse Ischemic Hindlimb Model.
    Kim JH; Lim IR; Park CY; Joo HJ; Noh JM; Choi SC; Hong SJ; Lim DS
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32245208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
    Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R
    Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of thymosin β4 expression with clinicopathological parameters and clinical outcomes of bladder cancer patients.
    Wang ZY; Zhang W; Yang JJ; Song DK; Wei JX; Gao S
    Neoplasma; 2016; 63(6):991-998. PubMed ID: 27596300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant adeno-associated virus carrying thymosin β
    Zheng XY; Lv YF; Li S; Li Q; Zhang QN; Zhang XT; Hao ZM
    World J Gastroenterol; 2017 Jan; 23(2):242-255. PubMed ID: 28127198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymosin β4 Regulates Focal Adhesion Formation in Human Melanoma Cells and Affects Their Migration and Invasion.
    Makowiecka A; Malek N; Mazurkiewicz E; Mrówczyńska E; Nowak D; Mazur AJ
    Front Cell Dev Biol; 2019; 7():304. PubMed ID: 31921836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thymosin β4 stabilizes hypoxia-inducible factor-1α protein in an oxygen-independent manner.
    Ock MS; Song KS; Kleinman H; Cha HJ
    Ann N Y Acad Sci; 2012 Oct; 1269():79-83. PubMed ID: 23045974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymosin Beta-4 Induces Mouse Hair Growth.
    Gao X; Liang H; Hou F; Zhang Z; Nuo M; Guo X; Liu D
    PLoS One; 2015; 10(6):e0130040. PubMed ID: 26083021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymosin β4: a potential molecular target for tumor therapy.
    Xiao Y; Chen Y; Wen J; Yan W; Zhou K; Cai W
    Crit Rev Eukaryot Gene Expr; 2012; 22(2):109-16. PubMed ID: 22856429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple potential roles of thymosin β4 in the growth and development of hair follicles.
    Dai B; Sha RN; Yuan JL; Liu DJ
    J Cell Mol Med; 2021 Feb; 25(3):1350-1358. PubMed ID: 33393222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SRF-MRTF signaling suppresses brown adipocyte development by modulating TGF-β/BMP pathway.
    Liu R; Xiong X; Nam D; Yechoor V; Ma K
    Mol Cell Endocrinol; 2020 Sep; 515():110920. PubMed ID: 32603734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis.
    Gal A; Sjöblom T; Fedorova L; Imreh S; Beug H; Moustakas A
    Oncogene; 2008 Feb; 27(9):1218-30. PubMed ID: 17724470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Steerable Induction of the Thymosin β4/MRTF-A Pathway via AAV-Based Overexpression Induces Therapeutic Neovascularization.
    Ziegler T; Kraus M; Husada W; Gesenhues F; Jiang Q; Pinkenburg O; Trenkwalder T; Laugwitz KL; le Noble F; Weber C; Kupatt C; Hinkel R
    Hum Gene Ther; 2017 Oct; ():. PubMed ID: 28726522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymosin β4 expression correlates with lymph node metastasis through hypoxia inducible factor-α induction in breast cancer.
    Yoon SY; Lee HR; Park Y; Kim JH; Kim SY; Yoon SR; Lee WJ; Cho BJ; Min H; Bang JW; Park H; Bang SI; Cho D
    Oncol Rep; 2011 Jan; 25(1):23-31. PubMed ID: 21109953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ahnak promotes tumor metastasis through transforming growth factor-β-mediated epithelial-mesenchymal transition.
    Sohn M; Shin S; Yoo JY; Goh Y; Lee IH; Bae YS
    Sci Rep; 2018 Sep; 8(1):14379. PubMed ID: 30258109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thymosin β4 has a major role in dermal burn wound healing that involves actin cytoskeletal remodelling via heat-shock protein 70.
    Kim S; Kwon J
    J Tissue Eng Regen Med; 2017 Apr; 11(4):1262-1273. PubMed ID: 25921810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-18-mediated interferon-gamma secretion is regulated by thymosin beta 4 in human NK cells.
    Lee HR; Yoon SY; Song SB; Park Y; Kim TS; Kim S; Hur DY; Song HK; Park H; Cho D
    Immunobiology; 2011 Oct; 216(10):1155-62. PubMed ID: 21742406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.